SCHEMBL23558324

SCHEMBL23558324

N#Cc1cc(-c2ncc(-c3ccc4c(c3)CCC(=O)N4)o2)ccc1CCC1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 3/20 0.39
▸ CYP11B2 P19099 3/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ PDE3B Q13370 3/20 0.39
▸ PDE3A Q14432 3/20 0.39
▸ CYP2C9 P11712 3/20 0.39
▸ IKBKE Q14164 1/20 0.39
▸ TBK1 Q9UHD2 1/20 0.39
▸ TBXAS1 P24557 1/20 0.39
▸ KIF11 P52732 1/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23524126 0.73 CDC7 (0.42) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL23558407 0.71 CYP1A2 (0.38) CYP11B1CYP11B2CYP1A2CYP2C9CYP2C19
SCHEMBL25856880 0.71 PGR (0.40) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL23524125 0.69 S1PR1 (0.40) S1PR1POLBBCL6
SCHEMBL16048052 0.66 CYP1A2 (0.54) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL16047246 0.66 CYP1A2 (0.54) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL3307911 0.66 KIF11 (0.58) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL23524015 0.66 CDC7 (0.42) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL30355553 0.65 MAPT (0.40) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL23523765 0.65 MAPT (0.40) CYP11B1CYP11B2CYP1A2PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CYP11B1 1869/4885CYP11B2 2298/4885CYP1A2 4278/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CYP11B1 1869/4885CYP11B2 2298/4885CYP1A2 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback